Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

The alpha7-nicotinic acetylcholine receptor and the pathology of hippocampal interneurons in schizophrenia.

Freedman R, Adams CE, Leonard S.

J Chem Neuroanat. 2000 Dec;20(3-4):299-306. Review.

PMID:
11207427
3.

Schizophrenia and the alpha7 nicotinic acetylcholine receptor.

Martin LF, Freedman R.

Int Rev Neurobiol. 2007;78:225-46. Review.

PMID:
17349863
4.

Nicotinic receptor function in schizophrenia.

Leonard S, Adams C, Breese CR, Adler LE, Bickford P, Byerley W, Coon H, Griffith JM, Miller C, Myles-Worsley M, Nagamoto HT, Rollins Y, Stevens KE, Waldo M, Freedman R.

Schizophr Bull. 1996;22(3):431-45. Review.

PMID:
8873294
5.

Therapeutic implications of a selective alpha7 nicotinic receptor abnormality in schizophrenia.

Deutsch SI, Rosse RB, Schwartz BL, Weizman A, Chilton M, Arnold DS, Mastropaolo J.

Isr J Psychiatry Relat Sci. 2005;42(1):33-44. Review.

6.

Glutamate and nicotinic receptor interactions in working memory: importance for the cognitive impairment of schizophrenia.

Timofeeva OA, Levin ED.

Neuroscience. 2011 Nov 10;195:21-36. doi: 10.1016/j.neuroscience.2011.08.038. Epub 2011 Aug 22. Review.

PMID:
21884762
7.

Inhibitory neurophysiological deficit as a phenotype for genetic investigation of schizophrenia.

Freedman R, Adams CE, Adler LE, Bickford PC, Gault J, Harris JG, Nagamoto HT, Olincy A, Ross RG, Stevens KE, Waldo M, Leonard S.

Am J Med Genet. 2000 Spring;97(1):58-64. Review.

PMID:
10813805
8.

Alpha7 neuronal nicotinic receptors as targets for novel therapies to treat multiple domains of schizophrenia.

Kucinski AJ, Stachowiak MK, Wersinger SR, Lippiello PM, Bencherif M.

Curr Pharm Biotechnol. 2011 Mar 1;12(3):437-48. Review.

PMID:
21133847
9.

Nicotinic receptors and functional regulation of GABA cell microcircuitry in bipolar disorder and schizophrenia.

Benes FM.

Handb Exp Pharmacol. 2012;(213):401-17. doi: 10.1007/978-3-642-25758-2_13. Review.

PMID:
23027422
10.

Studies on the hippocampal formation: From basic development to clinical applications: Studies on schizophrenia.

Freedman R, Goldowitz D.

Prog Neurobiol. 2010 Feb 9;90(2):263-75. doi: 10.1016/j.pneurobio.2009.10.008. Epub 2009 Oct 21. Review.

11.

Hippocampal pathology in schizophrenia.

Heckers S, Konradi C.

Curr Top Behav Neurosci. 2010;4:529-53. Review.

PMID:
21312412
12.

Hippocampal neurons in schizophrenia.

Heckers S, Konradi C.

J Neural Transm (Vienna). 2002 May;109(5-6):891-905. Review.

13.

GABAergic mechanisms of hippocampal hyperactivity in schizophrenia.

Heckers S, Konradi C.

Schizophr Res. 2015 Sep;167(1-3):4-11. doi: 10.1016/j.schres.2014.09.041. Epub 2014 Oct 18. Review.

14.

The genetics of sensory gating deficits in schizophrenia.

Freedman R, Olincy A, Ross RG, Waldo MC, Stevens KE, Adler LE, Leonard S.

Curr Psychiatry Rep. 2003 Jun;5(2):155-61. Review.

PMID:
12685995
15.

Neuronal ╬▒7 Nicotinic Receptors as a Target for the Treatment of Schizophrenia.

Wallace TL, Bertrand D.

Int Rev Neurobiol. 2015;124:79-111. doi: 10.1016/bs.irn.2015.08.003. Epub 2015 Sep 26. Review.

PMID:
26472526
16.

[Nicotine receptors, the hippocampus and schizophrenia].

Kaspárek T.

Cesk Fysiol. 2003 Dec;52(4):179-85. Review. Czech.

PMID:
15027152
17.

Role of nitric oxide and related molecules in schizophrenia pathogenesis: biochemical, genetic and clinical aspects.

Nasyrova RF, Ivashchenko DV, Ivanov MV, Neznanov NG.

Front Physiol. 2015 May 11;6:139. doi: 10.3389/fphys.2015.00139. eCollection 2015. Review.

18.

[The pathology of the hippocampus in schizophrenia].

Kolomeets NS.

Zh Nevrol Psikhiatr Im S S Korsakova. 2007;107(12):103-14. Review. Russian. No abstract available.

PMID:
18683339

Supplemental Content

Support Center